Safety, Tolerability, and Impact of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants with both Chronic Hepatitis B and HIV
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/immune-system-and-allergy.jpg)
Details
Age
Adult
Locations
CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Thomas Campbell](https://som.ucdenver.edu/FIMS/Content/faculty/4502/CU-Doctors-4502.jpg)
Thomas Campbell
Study ID
Protocol Number: 22-2156
More information available at ClinicalTrials.gov: NCT05551273
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers